Increased Activity‐Regulating and Neuroprotective Efficacy of α‐Secretase‐Derived Secreted Amyloid Precursor Protein Conferred by a C‐Terminal Heparin‐Binding Domain
Abstract
Abstract: Proteolytic cleavage of β‐amyloid precursor protein (βAPP) by α‐secretase results in release of one secreted form (sAPP) of APP (sAPPα), whereas cleavage by β‐secretase releases a C‐terminally truncated sAPP (sAPPβ) plus amyloid β‐peptide (Aβ). βAPP mutations linked to some inherited forms of Alzheimer's disease may alter its processing such that levels of sAPPα are reduced and levels of sAPPβ increased. sAPPαs may play important roles in neuronal plasticity and survival, whereas Aβ can be neurotoxic. sAPPα was ∼100‐fold more potent than sAPPβ in protecting hippocampal neurons against excitotoxicity, Aβ toxicity, and glucose deprivation. Whole‐cell patch clamp and calcium imaging analyses showed that sAPPβ was less effective than sAPPα in suppressing synaptic activity, activating K+ channels, and attenuating calcium responses to glutamate. Using various truncated sAPPα and sAPPβ APP695 products generated by eukaryotic and prokaryotic expression systems, and synthetic sAPP peptides, the activity of sAPPα was localized to amino acids 591–612 at the C‐terminus. Heparinases greatly reduced the actions of sAPPαs, indicating a role for a heparin‐binding domain at the C‐terminus of sAPPα in receptor activation. These findings indicate that alternative processing of βAPP has profound effects on the bioactivity of the resultant sAPP products and suggest that reduced levels of sAPPα could contribute to neuronal degeneration in Alzhiemer's disease.
Number of times cited: 188
- Liang Zhao, Yan Xiao, Jin Xiu, Long-Chun Tan and Zhi-Zhong Guan, Protection against the Neurotoxic Effects of β-Amyloid Peptide on Cultured Neuronal Cells by Lovastatin Involves Elevated Expression of α7 Nicotinic Acetylcholine Receptors and Activating Phosphorylation of Protein Kinases, The American Journal of Pathology, 10.1016/j.ajpath.2017.11.020, 188, 4, (1081-1093), (2018).
- Karim A. Alkadhi and An T. Dao, Exercise decreases BACE and APP levels in the hippocampus of a rat model of Alzheimer's disease, Molecular and Cellular Neuroscience, 86, (25), (2018).
- Max C Richter, Susann Ludewig, Alex Winschel, Tobias Abel, Charlotte Bold, Leonie R Salzburger, Susanne Klein, Kang Han, Sascha W Weyer, Ann‐Kristina Fritz, Bodo Laube, David P Wolfer, Christian J Buchholz, Martin Korte and Ulrike C Müller, Distinct in vivo roles of secreted APP ectodomain variants APPsα and APPsβ in regulation of spine density, synaptic plasticity, and cognition, The EMBO Journal, 37, 11, (2018).
- Zhuo Wang, Ya‐Hong Zhang, Wei Zhang, Hui‐Ling Gao, Man‐Li Zhong, Ting‐Ting Huang, Rui‐Fang Guo, Na‐Na Liu, Dan‐Dan Li, Yin Li, Zhan‐You Wang and Pu Zhao, Copper chelators promote nonamyloidogenic processing of AβPP via MT1/2/CREB‐dependent signaling pathways in AβPP/PS1 transgenic mice, Journal of Pineal Research, 65, 3, (2018).
- Ahsan Habib, Darrell Sawmiller and Jun Tan, Restoring Soluble Amyloid Precursor Protein α Functions as a Potential Treatment for Alzheimer's Disease, Journal of Neuroscience Research, 95, 4, (973-991), (2016).
- Julien Lalut, Delphine Karila, Patrick Dallemagne and Christophe Rochais, Modulating 5-HT4 and 5-HT6 receptors in Alzheimer’s disease treatment, Future Medicinal Chemistry, 9, 8, (781), (2017).
- Daniela Durand, Lila Carniglia, Juan Turati, Delia Ramírez, Julieta Saba, Carla Caruso and Mercedes Lasaga, Amyloid-beta neurotoxicity and clearance are both regulated by glial group II metabotropic glutamate receptors, Neuropharmacology, 10.1016/j.neuropharm.2017.05.008, 123, (274-286), (2017).
- Yasuhiko Kizuka, Shinobu Kitazume and Naoyuki Taniguchi, N -glycan and Alzheimer's disease, Biochimica et Biophysica Acta (BBA) - General Subjects, 1861, 10, (2447), (2017).
- Susann Ludewig and Martin Korte, Novel Insights into the Physiological Function of the APP (Gene) Family and Its Proteolytic Fragments in Synaptic Plasticity, Frontiers in Molecular Neuroscience, 9, (2017).
- Kelly Hares, James Scott Miners, Amelia Jane Cook, Claire Rice, Neil Scolding, Seth Love, Alastair Wilkins and Illana Gozes, Overexpression of Kinesin Superfamily Motor Proteins in Alzheimer’s Disease, Journal of Alzheimer's Disease, 60, 4, (1511), (2017).
- Htut Htut Htoo, Suveerawan Limsuvan, Onusa Thamsermsang, Jean-François Hernandez, Frédéric Checler, Piyarat Govitrapong, Narawut Pakaprot, Pravit Akarasereenont, Bruno Vincent and Madepalli K. Lakshmana, The Polyherbal Wattana Formula Displays Anti-Amyloidogenic Properties by Increasing α-Secretase Activities, PLOS ONE, 12, 1, (e0170360), (2017).
- S. Marcelli, E. Ficulle, L. Piccolo, M. Corbo and M. Feligioni, An overview of the possible therapeutic role of SUMOylation in the treatment of Alzheimer’s disease, Pharmacological Research, (2017).
- Emilie Dorard, Stéphanie Chasseigneaux, Lucie Gorisse-Hussonnois, Cédric Broussard, Thierry Pillot and Bernadette Allinquant, Soluble Amyloid Precursor Protein Alpha Interacts with alpha3-Na, K-ATPAse to Induce Axonal Outgrowth but Not Neuroprotection: Evidence for Distinct Mechanisms Underlying these Properties, Molecular Neurobiology, (2017).
- Zhi-Qiang Xu, Huang Huang, Ya-Li Chen, Yun-Ying Gao, Jun Xu, Charles Marshall, Zhi-You Cai and Ming Xiao, Different Expression Patterns of Amyloid-β Protein Precursor Secretases in Human and Mouse Hippocampal Neurons: A Potential Contribution to Species Differences in Neuronal Susceptibility to Amyloid-β Pathogenesis, Journal of Alzheimer's Disease, 51, 1, (179), (2016).
- Akanksha Kulshreshtha and Poonam Piplani, Current pharmacotherapy and putative disease-modifying therapy for Alzheimer’s disease, Neurological Sciences, 37, 9, (1403), (2016).
- Robert J. Andrew, Katherine A. B. Kellett, Gopal Thinakaran and Nigel M. Hooper, A Greek Tragedy: The Growing Complexity of Alzheimer Amyloid Precursor Protein Proteolysis, Journal of Biological Chemistry, 10.1074/jbc.R116.746032, 291, 37, (19235-19244), (2016).
- Stephanie Plummer, Corinna Van den Heuvel, Emma Thornton, Frances Corrigan and Roberto Cappai, The Neuroprotective Properties of the Amyloid Precursor Protein Following Traumatic Brain Injury, Aging and Disease, 10.14336/AD.2015.0907, 7, 2, (163), (2016).
- Arpita Kundu, Nelli Milosch, Patrick Antonietti, Frederik Baumkötter, Andreas Zymny, Ulrike C. Müller, Stefan Kins, Parvana Hajieva, Christian Behl and Donat Kögel, Modulation of BAG3 Expression and Proteasomal Activity by sAPPα Does Not Require Membrane-Tethered Holo-APP, Molecular Neurobiology, 53, 9, (5985), (2016).
- Zheng-Xu Cai, Hui-Shu Guo, Che Wang, Min Wei, Cheng Cheng, Zhao-Fei Yang, Yin-Wang Chen, Wei-Dong Le and Song Li, Double-Edged Roles of Nitric Oxide Signaling on APP Processing and Amyloid-β Production In Vitro: Preliminary Evidence from Sodium Nitroprusside, Neurotoxicity Research, 29, 1, (21), (2016).
- Romain Fol, Jerome Braudeau, Susann Ludewig, Tobias Abel, Sascha W. Weyer, Jan-Peter Roederer, Florian Brod, Mickael Audrain, Alexis-Pierre Bemelmans, Christian J. Buchholz, Martin Korte, Nathalie Cartier and Ulrike C. Müller, Viral gene transfer of APPsα rescues synaptic failure in an Alzheimer’s disease mouse model, Acta Neuropathologica, 131, 2, (247), (2016).
- Jiraporn Panmanee, Chutikorn Nopparat, Napapit Chavanich, Mayuri Shukla, Sujira Mukda, Weihong Song, Bruno Vincent and Piyarat Govitrapong, Melatonin regulates the transcription of βAPP‐cleaving secretases mediated through melatonin receptors in human neuroblastoma SH‐SY5Y cells, Journal of Pineal Research, 59, 3, (308-320), (2015).
- Jie Dai, Zhen-Quan Liu, Xiao-Qin Wang, Jing Lin, Pei-Fen Yao, Shi-Liang Huang, Tian-Miao Ou, Jia-Heng Tan, Ding Li, Lian-Quan Gu and Zhi-Shu Huang, Discovery of Small Molecules for Up-Regulating the Translation of Antiamyloidogenic Secretase, a Disintegrin and Metalloproteinase 10 (ADAM10), by Binding to the G-Quadruplex-Forming Sequence in the 5′ Untranslated Region (UTR) of Its mRNA, Journal of Medicinal Chemistry, 58, 9, (3875), (2015).
- Ruth MacLeod, Ellin-Kristina Hillert, Ryan T Cameron and George S Baillie, The role and therapeutic targeting of α-, β- and γ-secretase in Alzheimer's disease, Future Science OA, 1, 3, (2015).
- Takashi Hosono, Akihiro Mouri, Kazuchika Nishitsuji, Cha-Gyun Jung, Masanori Kontani, Hisanori Tokuda, Hiroshi Kawashima, Hiroshi Shibata, Toshiharu Suzuki, Toshitaka Nabehsima and Makoto Michikawa, Arachidonic or Docosahexaenoic Acid Diet Prevents Memory Impairment in Tg2576 Mice, Journal of Alzheimer's Disease, 48, 1, (149), (2015).
- Hoang S. Nhan, Karen Chiang and Edward H. Koo, The multifaceted nature of amyloid precursor protein and its proteolytic fragments: friends and foes, Acta Neuropathologica, 10.1007/s00401-014-1347-2, 129, 1, (1-19), (2014).
- Meike Hick, Ulrike Herrmann, Sascha W. Weyer, Jan-Philipp Mallm, Jakob-Andreas Tschäpe, Marianne Borgers, Marc Mercken, Fabian C. Roth, Andreas Draguhn, Lutz Slomianka, David P. Wolfer, Martin Korte and Ulrike C. Müller, Acute function of secreted amyloid precursor protein fragment APPsα in synaptic plasticity, Acta Neuropathologica, 129, 1, (21), (2015).
- Jung Kwon Lee, Eunice C. Y. Li-Chan and Hee-Guk Byun, Characterization of β-secretase inhibitory peptide purified from skate skin protein hydrolysate, European Food Research and Technology, 240, 1, (129), (2015).
- Frances Corrigan, Emma Thornton, Laila C. Roisman, Anna V. Leonard, Robert Vink, Peter C. Blumbergs, Corinna den Heuvel and Roberto Cappai, The neuroprotective activity of the amyloid precursor protein against traumatic brain injury is mediated via the heparin binding site in residues 96‐110, Journal of Neurochemistry, 128, 1, (196-204), (2013).
- Sally Hunter and Carol Brayne, Integrating the molecular and the population approaches to dementia research to help guide the future development of appropriate therapeutics, Biochemical Pharmacology, 10.1016/j.bcp.2013.12.015, 88, 4, (652-660), (2014).
- Mikiko Ohno, Yoshinori Hiraoka, Stefan F. Lichtenthaler, Kiyoto Nishi, Sayaka Saijo, Tatsuhiko Matsuoka, Hidekazu Tomimoto, Wataru Araki, Ryosuke Takahashi, Toru Kita, Takeshi Kimura and Eiichiro Nishi, Nardilysin prevents amyloid plaque formation by enhancing α-secretase activity in an Alzheimer's disease mouse model, Neurobiology of Aging, 10.1016/j.neurobiolaging.2013.07.014, 35, 1, (213-222), (2014).
- N Milosch, G Tanriöver, A Kundu, A Rami, J-C François, F Baumkötter, S W Weyer, A Samanta, A Jäschke, F Brod, C J Buchholz, S Kins, C Behl, U C Müller and D Kögel, Holo-APP and G-protein-mediated signaling are required for sAPPα-induced activation of the Akt survival pathway, Cell Death & Disease, 5, 8, (e1391), (2014).
- Sergio Rosales-Mendoza, Néstor Rubio-Infante, Sergio Zarazúa, Dania O Govea-Alonso, Guadalupe Martel-Gallegos and Leticia Moreno-Fierros, Plant-based vaccines for Alzheimer's disease: an overview, Expert Review of Vaccines, 13, 3, (429), (2014).
- Hidemi Yoshida, Pengfei Meng, Tomoh Matsumiya, Kunikazu Tanji, Ryo Hayakari, Fei Xing, Liang Wang, Kazushi Tsuruga, Hiroshi Tanaka, Junsei Mimura, Kunio Kosaka, Ken Itoh, Ippei Takahashi and Tadaatsu Imaizumi, Carnosic acid suppresses the production of amyloid-β 1-42 and 1-43 by inducing an α-secretase TACE/ADAM17 in U373MG human astrocytoma cells, Neuroscience Research, 79, (83), (2014).
- Elisa Canepa, Cinzia Domenicotti, Barbara Marengo, Mario Passalacqua, Umberto M. Marinari, Maria A. Pronzato, Ernesto Fedele and Roberta Ricciarelli, Cyclic adenosine monophosphate as an endogenous modulator of the amyloid‐β precursor protein metabolism, IUBMB Life, 65, 2, (127-133), (2013).
- Neha Kabra Woods and Jaya Padmanabhan, Inhibition of Amyloid Precursor Protein Processing Enhances Gemcitabine-mediated Cytotoxicity in Pancreatic Cancer Cells, Journal of Biological Chemistry, 288, 42, (30114), (2013).
- Ina Tesseur, Anna A. Pimenova, Adrian C. Lo, Marta Ciesielska, Stefan F. Lichtenthaler, Joris H. De Maeyer, Jan A.J. Schuurkes, Rudi D'Hooge and Bart De Strooper, Chronic 5-HT4 receptor activation decreases Aβ production and deposition in hAPP/PS1 mice, Neurobiology of Aging, 34, 7, (1779), (2013).
- Kenneth Hensley, S. Prasad Gabbita, Kalina Venkova, Alexandar Hristov, Ming F. Johnson, Pirooz Eslami and Marni E. Harris-White, A Derivative of the Brain Metabolite Lanthionine Ketimine Improves Cognition and Diminishes Pathology in the 3×Tg-AD Mouse Model of Alzheimer Disease, Journal of Neuropathology & Experimental Neurology, 10.1097/NEN.0b013e3182a74372, 72, 10, (955-969), (2013).
- Haibo Wang, Rena Li and Yong Shen, β-Secretase: its biology as a therapeutic target in diseases, Trends in Pharmacological Sciences, 10.1016/j.tips.2013.01.008, 34, 4, (215-225), (2013).
- Pengfei Meng, Hidemi Yoshida, Tomoh Matsumiya, Tadaatsu Imaizumi, Kunikazu Tanji, Fei Xing, Ryo Hayakari, Junichi Dempoya, Tetsuya Tatsuta, Tomomi Aizawa-Yashiro, Junsei Mimura, Kunio Kosaka, Ken Itoh and Kei Satoh, Carnosic acid suppresses the production of amyloid-β 1–42 by inducing the metalloprotease gene TACE/ADAM17 in SH-SY5Y human neuroblastoma cells, Neuroscience Research, 75, 2, (94), (2013).
- Zhi Y. Guo, Cheng Z. Li, Xiao J. Li, Ya L. Wang, Mark P. Mattson and Cheng B. Lu, The developmental regulation of glutamate receptor-mediated calcium signaling in primary cultured rat hippocampal neurons, NeuroReport, 24, 9, (492), (2013).
- Y.A. Lim, L.A. Murray, M.K.P. Lai and C. Chen, NeuroAiD ® (MLC601) and Amyloid Precursor Protein Processing , Cerebrovascular Diseases, 10.1159/000346236, 35, s1, (30-37), (2013).
- Haythum O Tayeb, Evan D Murray, Bruce H Price and Frank I Tarazi, Bapineuzumab and solanezumab for Alzheimer's disease: is the ‘amyloid cascade hypothesis' still alive?, Expert Opinion on Biological Therapy, 13, 7, (1075), (2013).
- A. V. Maltsev, N. V. Dovidchenko, V. K. Uteshev, V. V. Sokolik, O. M. Shtang, M. A. Yakushin, N. M. Sokolova, A. K. Surin and O. V. Galzitskaya, Intensive protein synthesis in neurons and phosphorylation of beta-amyloid precursor protein and tau-protein are triggering factors of neuronal amyloidosis and Alzheimer’s disease, Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, 7, 4, (278), (2013).
- Alessio Colombo, Huanhuan Wang, Peer-Hendrik Kuhn, Richard Page, Elisabeth Kremmer, Peter J. Dempsey, Howard C. Crawford and Stefan F. Lichtenthaler, Constitutive α- and β-secretase cleavages of the amyloid precursor protein are partially coupled in neurons, but not in frequently used cell lines, Neurobiology of Disease, 49, (137), (2013).
- Noriko Hasebe, Yuki Fujita, Masaki Ueno, Kazuhiro Yoshimura, Yuji Fujino, Toshihide Yamashita and Koichi M. Iijima, Soluble β-amyloid Precursor Protein Alpha Binds to p75 Neurotrophin Receptor to Promote Neurite Outgrowth, PLoS ONE, 8, 12, (e82321), (2013).
- Brian Giunta and Jun Tan, Green Tea (−)-Epigallocatechin-3-Gallate and Amyloid Precursor Protein, Tea in Health and Disease Prevention, 10.1016/B978-0-12-384937-3.00118-X, (1411-1423), (2013).
- Sally Hunter, Thomas Arendt and Carol Brayne, The Senescence Hypothesis of Disease Progression in Alzheimer Disease: an Integrated Matrix of Disease Pathways for FAD and SAD, Molecular Neurobiology, 48, 3, (556), (2013).
- Chi Hyun Kim and Yeong-Min Yoo, Altered APP Carboxyl-Terminal Processing Under Ferrous Iron Treatment in PC12 Cells, The Korean Journal of Physiology & Pharmacology, 17, 3, (189), (2013).
- Gunnar Brinkmalm, Ann Brinkmalm, Philippe Bourgeois, Rita Persson, Oskar Hansson, Erik Portelius, Marc Mercken, Ulf Andreasson, Stéphane Parent, Francesco Lipari, Annika Öhrfelt, Maria Bjerke, Lennart Minthon, Henrik Zetterberg, Kaj Blennow and Magdalena Nutu, Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease, Brain Research, 1513, (117), (2013).
- Michael P. Demars, Carolyn Hollands, Kai Da (Tommy) Zhao and Orly Lazarov, Soluble amyloid precursor protein-α rescues age-linked decline in neural progenitor cell proliferation, Neurobiology of Aging, 10.1016/j.neurobiolaging.2013.04.016, 34, 10, (2431-2440), (2013).
- Maud Cochet, Romain Donneger, Elisabeth Cassier, Florence Gaven, Stefan F. Lichtenthaler, Philippe Marin, Joël Bockaert, Aline Dumuis and Sylvie Claeysen, 5-HT4 Receptors Constitutively Promote the Non-Amyloidogenic Pathway of APP Cleavage and Interact with ADAM10, ACS Chemical Neuroscience, 4, 1, (130), (2013).
- Daniela Kaden, Anja Harmeier, Christoph Weise, Lisa M. Munter, Veit Althoff, Benjamin R. Rost, Peter W. Hildebrand, Dietmar Schmitz, Michael Schaefer, Rudi Lurz, Sabine Skodda, Raina Yamamoto, Sönke Arlt, Ulrich Finckh and Gerd Multhaup, Novel APP/Aβ mutation K16N produces highly toxic heteromeric Aβ oligomers, EMBO Molecular Medicine, 4, 7, (647-659), (2012).
- Valérie Vingtdeux and Philippe Marambaud, Identification and biology of α‐secretase, Journal of Neurochemistry, 120, s1, (34-45), (2011).
- Stéphanie Chasseigneaux and Bernadette Allinquant, Functions of Aβ, sAPPα and sAPPβ : similarities and differences, Journal of Neurochemistry, 120, s1, (99-108), (2011).
- Seung T. Lim, Allison Chang, Rita E. Giuliano and Howard J. Federoff, Ectodomain shedding of nectin‐1 regulates the maintenance of dendritic spine density, Journal of Neurochemistry, 120, 5, (741-751), (2011).
- Sara Baratchi, Jane Evans, Warren P. Tate, Wickliffe C. Abraham and Bronwen Connor, Secreted amyloid precursor proteins promote proliferation and glial differentiation of adult hippocampal neural progenitor cells, Hippocampus, 22, 7, (1517-1527), (2011).
- Han Zhang, Qilin Ma, Yun‐wu Zhang and Huaxi Xu, Proteolytic processing of Alzheimer’s β‐amyloid precursor protein, Journal of Neurochemistry, 120, s1, (9-21), (2011).
- Haythum O. Tayeb, Hyun Duk Yang, Bruce H. Price and Frank I. Tarazi, Pharmacotherapies for Alzheimer's disease: Beyond cholinesterase inhibitors, Pharmacology & Therapeutics, 134, 1, (8), (2012).
- Hyun Duk Yang, Dong-Hwan Ho, Myoung-Jea Yi, Wongi Seol and Sang Yun Kim, Misfolded Proteins in Neurodegenerative Dementias: Molecular Mechanisms, Dementia and Neurocognitive Disorders, 11, 2, (38), (2012).
- Andreas Schrötter, Kathy Pfeiffer, Fouzi El Magraoui, Harald W. Platta, Ralf Erdmann, Helmut E. Meyer, Rupert Egensperger, Katrin Marcus and Thorsten Müller, The Amyloid Precursor Protein (APP) Family Members are Key Players in S-adenosylmethionine Formation by MAT2A and ModifyBACE1andPSEN1Gene Expression-Relevance for Alzheimer's Disease, Molecular & Cellular Proteomics, 11, 11, (1274), (2012).
- Daniela Kaden, Lisa Marie Munter, Bernd Reif and Gerd Multhaup, The amyloid precursor protein and its homologues: Structural and functional aspects of native and pathogenic oligomerization, European Journal of Cell Biology, 91, 4, (234), (2012).
- Frances Corrigan, Robert Vink, Peter C. Blumbergs, Colin L. Masters, Roberto Cappai and Corinna van den Heuvel, Evaluation of the effects of treatment with sAPPα on functional and histological outcome following controlled cortical impact injury in mice, Neuroscience Letters, 515, 1, (50), (2012).
- Neeta Khandekar, Khun Hong Lie, Perminder S. Sachdev and Kuldip S. Sidhu, Amyloid Precursor Proteins, Neural Differentiation of Pluripotent Stem Cells and Its Relevance to Alzheimer's Disease, Stem Cells and Development, 10.1089/scd.2011.0564, 21, 7, (997-1006), (2012).
- Loredana Spoerri, Kevin Barnham, Gerd Multhaup and Roberto Cappaise, Role of the Amyloid Precursor Protein and Copper in Alzheimer’s Disease, Brain Diseases and Metalloproteins, 10.1201/b12777-7, (169-220), (2012).
- Krista Lanctôt, Ida Kircanski, Sarah Chau and Nathan Herrmann, The Current Status of Alzheimer's Disease Treatment, Alzheimer's Disease, 10.1201/b11986-5, (117-161), (2012).
- Frances Corrigan, Robert Vink, Peter C. Blumbergs, Colin L. Masters, Roberto Cappai and Corinna van den Heuvel, Characterisation of the effect of knockout of the amyloid precursor protein on outcome following mild traumatic brain injury, Brain Research, 10.1016/j.brainres.2012.02.045, 1451, (87-99), (2012).
- Demian Obregon, Huayan Hou, Juan Deng, Brian Giunta, Jun Tian, Donna Darlington, Md Shahaduzzaman, Yuyuan Zhu, Takashi Mori, Mark P. Mattson and Jun Tan, Soluble amyloid precursor protein-α modulates β-secretase activity and amyloid-β generation, Nature Communications, 3, 1, (2012).
- Stefan F. Lichtenthaler, Alpha‐secretase in Alzheimer’s disease: molecular identity, regulation and therapeutic potential, Journal of Neurochemistry, 116, 1, (10-21), (2010).
- Sascha W Weyer, Maja Klevanski, Andrea Delekate, Vootele Voikar, Dorothee Aydin, Meike Hick, Mikhail Filippov, Natalia Drost, Kristin L Schaller, Martina Saar, Miriam A Vogt, Peter Gass, Ayan Samanta, Andres Jäschke, Martin Korte, David P Wolfer, John H Caldwell and Ulrike C Müller, APP and APLP2 are essential at PNS and CNS synapses for transmission, spatial learning and LTP, The EMBO Journal, 30, 11, (2266-2280), (2011).
- Stefan F. Lichtenthaler, Christian Haass and Harald Steiner, Regulated intramembrane proteolysis – lessons from amyloid precursor protein processing, Journal of Neurochemistry, 117, 5, (779-796), (2011).
- Sven Lammich, Frits Kamp, Judith Wagner, Brigitte Nuscher, Sonja Zilow, Ann-Katrin Ludwig, Michael Willem and Christian Haass, Translational Repression of the Disintegrin and Metalloprotease ADAM10 by a Stable G-quadruplex Secondary Structure in Its 5′-Untranslated Region, Journal of Biological Chemistry, 286, 52, (45063), (2011).
- Balmiki Ray, Justin M. Long, Deborah K. Sokol, Debomoy K. Lahiri and Ashley I. Bush, Increased Secreted Amyloid Precursor Protein-α (sAPPα) in Severe Autism: Proposal of a Specific, Anabolic Pathway and Putative Biomarker, PLoS ONE, 6, 6, (e20405), (2011).
- Amantha Thathiah and Bart De Strooper, The role of G protein-coupled receptors in the pathology of Alzheimer's disease, Nature Reviews Neuroscience, 10.1038/nrn2977, 12, 2, (73-87), (2011).
- Sebastian Hogl, Peer-Hendrik Kuhn, Alessio Colombo, Stefan F. Lichtenthaler and Koichi M. Iijima, Determination of the Proteolytic Cleavage Sites of the Amyloid Precursor-Like Protein 2 by the Proteases ADAM10, BACE1 and γ-Secretase, PLoS ONE, 6, 6, (e21337), (2011).
- Lucilla Parnetti and Davide Chiasserini, Role of CSF biomarkers in the diagnosis of prodromal Alzheimer’s disease, Biomarkers in Medicine, 5, 4, (479), (2011).
- Frances Corrigan, Chi L.L. Pham, Robert Vink, Peter C. Blumbergs, Colin L. Masters, Corinna van den Heuvel and Roberto Cappai, The neuroprotective domains of the amyloid precursor protein, in traumatic brain injury, are located in the two growth factor domains, Brain Research, 1378, (137), (2011).
- Nathan Herrmann, Sarah A. Chau, Ida Kircanski and Krista L. Lanctôt, Current and Emerging Drug Treatment Options for Alzheimerʼs Disease, Drugs, 10.2165/11595870-000000000-00000, 71, 15, (2031-2065), (2011).
- Stéphanie Chasseigneaux, Levent Dinc, Christiane Rose, Claude Chabret, Fanny Coulpier, Piotr Topilko, Gweltas Mauger, Bernadette Allinquant and Maria Deli, Secreted Amyloid Precursor Protein β and Secreted Amyloid Precursor Protein α Induce Axon Outgrowth In Vitro through Egr1 Signaling Pathway, PLoS ONE, 6, 1, (e16301), (2011).
- Ana Nunes, Sarah N.R. Pressey, Jonathan D. Cooper and Salvador Soriano, Loss of amyloid precursor protein in a mouse model of Niemann–Pick type C disease exacerbates its phenotype and disrupts tau homeostasis, Neurobiology of Disease, 10.1016/j.nbd.2011.01.028, 42, 3, (349-359), (2011).
- Zhi-dong Zhou, Christine Hui-shan Chan, Quan-hong Ma, Xiao-hong Xu, Zhi-cheng Xiao and Eng-King Tan, The roles of amyloid precursor protein (APP) in neurogenesis, Cell Adhesion & Migration, 10.4161/cam.5.4.16986, 5, 4, (280-292), (2014).
- Jason A. Bailey, Balmiki Ray, Nigel H. Greig, Debomoy K. Lahiri and Mark P. Mattson, Rivastigmine Lowers Aβ and Increases sAPPα Levels, Which Parallel Elevated Synaptic Markers and Metabolic Activity in Degenerating Primary Rat Neurons, PLoS ONE, 6, 7, (e21954), (2011).
- Simonetta Camandola and Mark P. Mattson, Aberrant subcellular neuronal calcium regulation in aging and Alzheimer's disease, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1813, 5, (965), (2011).
- Peer‐Hendrik Kuhn, Huanhuan Wang, Bastian Dislich, Alessio Colombo, Ulrike Zeitschel, Joachim W Ellwart, Elisabeth Kremmer, Steffen Roßner and Stefan F Lichtenthaler, ADAM10 is the physiologically relevant, constitutive α‐secretase of the amyloid precursor protein in primary neurons, The EMBO Journal, 29, 17, (3020-3032), (2010).
- Sylvia Ullrich, Anna Münch, Stephanie Neumann, Elisabeth Kremmer, Jörg Tatzelt and Stefan F. Lichtenthaler, The Novel Membrane Protein TMEM59 Modulates Complex Glycosylation, Cell Surface Expression, and Secretion of the Amyloid Precursor Protein, Journal of Biological Chemistry, 285, 27, (20664), (2010).
- James A. Duce, Andrew Tsatsanis, Michael A. Cater, Simon A. James, Elysia Robb, Krutika Wikhe, Su Ling Leong, Keyla Perez, Timothy Johanssen, Mark A. Greenough, Hyun-Hee Cho, Denise Galatis, Robert D. Moir, Colin L. Masters, Catriona McLean, Rudolph E. Tanzi, Roberto Cappai, Kevin J. Barnham, Giuseppe D. Ciccotosto, Jack T. Rogers and Ashley I. Bush, Iron-Export Ferroxidase Activity of β-Amyloid Precursor Protein Is Inhibited by Zinc in Alzheimer's Disease, Cell, 142, 6, (857), (2010).
- H. Jang, F. T. Arce, S. Ramachandran, R. Capone, R. Azimova, B. L. Kagan, R. Nussinov and R. Lal, Truncated -amyloid peptide channels provide an alternative mechanism for Alzheimer's Disease and Down syndrome, Proceedings of the National Academy of Sciences, 107, 14, (6538), (2010).
- Ana Gabriela Henriques, Sandra Isabel Vieira, Maria Elena Crespo‐López, Márcio A. Guiomar de Oliveira, Edgar F. da Cruz e Silva and Odete A.B. da Cruz e Silva, Intracellular sAPP retention in response to Aβ is mapped to cytoskeleton‐associated structures, Journal of Neuroscience Research, 87, 6, (1449-1461), (2008).
- Qiongman Kong, Troy S. Peterson, Olga Baker, Emily Stanley, Jean Camden, Cheikh I. Seye, Laurie Erb, Agnes Simonyi, W. Gibson Wood, Grace Y. Sun and Gary A. Weisman, Interleukin‐1β enhances nucleotide‐induced and α‐secretase‐dependent amyloid precursor protein processing in rat primary cortical neurons via up‐regulation of the P2Y2 receptor, Journal of Neurochemistry, 109, 5, (1300-1310), (2009).
- Sandra Isabel Vieira, Sandra Rebelo, Sara Catarina Domingues, Edgar F. da Cruz e Silva and Odete A. B. da Cruz e Silva, S655 phosphorylation enhances APP secretory traffic, Molecular and Cellular Biochemistry, 328, 1-2, (145), (2009).
- Karina Reiss and Paul Saftig, The “A Disintegrin And Metalloprotease” (ADAM) family of sheddases: Physiological and cellular functions, Seminars in Cell & Developmental Biology, 20, 2, (126), (2009).
- Francesco Panza, Vincenzo Solfrizzi, Vincenza Frisardi, Cristiano Capurso, Alessia DʼIntrono, Anna M. Colacicco, Gianluigi Vendemiale, Antonio Capurso and Bruno P. Imbimbo, Disease-Modifying Approach to the Treatment of Alzheimerʼs Disease, Drugs & Aging, 26, 7, (537), (2009).
- N.R. Pandey, K. Sultan, E. Twomey and D.L. Sparks, Phospholipids block nuclear factor-kappa B and tau phosphorylation and inhibit amyloid-beta secretion in human neuroblastoma cells, Neuroscience, 164, 4, (1744), (2009).
- Minji Kim, Jaehong Suh, Donna Romano, Mimy H. Truong, Kristina Mullin, Basavaraj Hooli, David Norton, Giuseppina Tesco, Kathy Elliott, Steven L. Wagner, Robert D. Moir, K. David Becker and Rudolph E. Tanzi, Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate α-secretase activity, Human Molecular Genetics, 18, 20, (3987), (2009).
- Thomas Arendt, Synaptic degeneration in Alzheimer’s disease, Acta Neuropathologica, 118, 1, (167), (2009).
- Jinu Lee, Chul Hoon Kim, Dong Goo Kim and Young Soo Ahn, Zinc Inhibits Amyloid β Production from Alzheimer's Amyloid Precursor Protein in SH-SY5Y Cells, The Korean Journal of Physiology and Pharmacology, 13, 3, (195), (2009).
- Francesca Argellati, Cinzia Domenicotti, Mario Passalacqua, Elzbieta Janda, Edon Melloni, Umberto M. Marinari, Maria A. Pronzato and Roberta Ricciarelli, Protein kinase C-dependent α-secretory processing of the amyloid precursor protein is mediated by phosphorylation of myosin II-B, The FASEB Journal, 23, 4, (1246), (2009).
- Yuriko Tachida, Kazuhiro Nakagawa, Takashi Saito, Takaomi C. Saido, Takashi Honda, Yuko Saito, Shigeo Murayama, Tamao Endo, Gaku Sakaguchi, Akira Kato, Shinobu Kitazume and Yasuhiro Hashimoto, Interleukin‐1β up‐regulates TACE to enhance α‐cleavage of APP in neurons: resulting decrease in Aβ production, Journal of Neurochemistry, 104, 5, (1387-1393), (2007).
- Chanel J. Taylor, David R. Ireland, Irene Ballagh, Katie Bourne, Nicola M. Marechal, Paul R. Turner, David K. Bilkey, Warren P. Tate and Wickliffe C. Abraham, Endogenous secreted amyloid precursor protein-α regulates hippocampal NMDA receptor function, long-term potentiation and spatial memory, Neurobiology of Disease, 31, 2, (250), (2008).
- Kavon Rezai-Zadeh, Gary W. Arendash, Huayan Hou, Frank Fernandez, Maren Jensen, Melissa Runfeldt, R. Douglas Shytle and Jun Tan, Green tea epigallocatechin-3-gallate (EGCG) reduces β-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice, Brain Research, 1214, (177), (2008).
- Elena Marcello, Roberta Epis and Monica Di Luca, Amyloid flirting with synaptic failure: Towards a comprehensive view of Alzheimer's disease pathogenesis, European Journal of Pharmacology, 585, 1, (109), (2008).
- A.B. Clement, R. Hanstein, A. Schröder, H. Nagel, K. Endres, F. Fahrenholz and C. Behl, Effects of neuron-specific ADAM10 modulation in an in vivo model of acute excitotoxic stress, Neuroscience, 152, 2, (459), (2008).
- Xiao‐Xin Yan, Kun Xiong, Xue‐Gang Luo, Robert G. Struble and Richard W. Clough, β‐secretase expression in normal and functionally deprived rat olfactory bulbs: Inverse correlation with oxidative metabolic activity, Journal of Comparative Neurology, 501, 1, (52-69), (2007).
- Tobias Hartmann, Johannna Kuchenbecker and Marcus O. W. Grimm, Alzheimer’s disease: the lipid connection, Journal of Neurochemistry, 103, (159-170), (2007).
- Yoshinori Hiraoka, Mikiko Ohno, Kazuhiro Yoshida, Katsuya Okawa, Hidekazu Tomimoto, Toru Kita and Eiichiro Nishi, Enhancement of α‐secretase cleavage of amyloid precursor protein by a metalloendopeptidase nardilysin, Journal of Neurochemistry, 102, 5, (1595-1605), (2007).
- Benedict C. Albensi, Derek R. Oliver, Justin Toupin and Gary Odero, Electrical stimulation protocols for hippocampal synaptic plasticity and neuronal hyper-excitability: Are they effective or relevant?, Experimental Neurology, 204, 1, (1), (2007).
- Paul R. Turner, Katie Bourne, Daniel Garama, Alan Carne, Wickliffe C. Abraham and Warren P. Tate, Production, purification and functional validation of human secreted amyloid precursor proteins for use as neuropharmacological reagents, Journal of Neuroscience Methods, 10.1016/j.jneumeth.2007.04.001, 164, 1, (68-74), (2007).
- H. Ma, S. Lesne, L. Kotilinek, J. V. Steidl-Nichols, M. Sherman, L. Younkin, S. Younkin, C. Forster, N. Sergeant, A. Delacourte, R. Vassar, M. Citron, P. Kofuji, L. M. Boland and K. H. Ashe, Involvement of -site APP cleaving enzyme 1 (BACE1) in amyloid precursor protein-mediated enhancement of memory and activity-dependent synaptic plasticity, Proceedings of the National Academy of Sciences, 104, 19, (8167), (2007).
- Matthias Gralle and Sérgio T. Ferreira, Structure and functions of the human amyloid precursor protein: The whole is more than the sum of its parts, Progress in Neurobiology, 82, 1, (11), (2007).
- HUAXI XU, RUISHAN WANG, YUN‐WU ZHANG and XUE ZHANG, Estrogen, β‐Amyloid Metabolism/Trafficking, and Alzheimer's Disease, Annals of the New York Academy of Sciences, 1089, 1, (324-342), (2006).
- Chengbiao Lu, Yue Wang, Katsutoshi Furukawa, Weiming Fu, Xin Ouyang and Mark P. Mattson, Evidence that caspase‐1 is a negative regulator of AMPA receptor‐mediated long‐term potentiation at hippocampal synapses, Journal of Neurochemistry, 97, 4, (1104-1110), (2006).
- Sanghamitra Bandyopadhyay, Dean M. Hartley, Catherine M. Cahill, Debomay K. Lahiri, Naibedya Chattopadhyay and Jack T. Rogers, Interleukin‐1α stimulates non‐amyloidogenic pathway by α‐secretase (ADAM‐10 and ADAM‐17) cleavage of APP in human astrocytic cells involving p38 MAP kinase, Journal of Neuroscience Research, 84, 1, (106-118), (2006).
- Susanne Schöbel, Stephanie Neumann, Brian Seed and Stefan F. Lichtenthaler, Expression cloning screen for modifiers of amyloid precursor protein shedding, International Journal of Developmental Neuroscience, 10.1016/j.ijdevneu.2005.11.003, 24, 2-3, (141-148), (2006).
- Emma Thornton, Robert Vink, Peter C. Blumbergs and Corinna Van Den Heuvel, Soluble amyloid precursor protein α reduces neuronal injury and improves functional outcome following diffuse traumatic brain injury in rats, Brain Research, 1094, 1, (38), (2006).
- Karen F.S. Bell and A. Claudio Cuello, Altered synaptic function in Alzheimer's disease, European Journal of Pharmacology, 545, 1, (11), (2006).
- Amy J. Marshall, Marcus Rattray and Peter F.T. Vaughan, Chronic hypoxia in the human neuroblastoma SH-SY5Y causes reduced expression of the putative α-secretases, ADAM10 and TACE, without altering their mRNA levels, Brain Research, 1099, 1, (18), (2006).
- Silvia Naus, Simone Reipschläger, Dirk Wildeboer, Stefan F. Lichtenthaler, Stefan Mitterreiter, Ziqiang Guan, Marcia L. Moss and Jörg W. Bartsch, Identification of candidate substrates for ectodomain shedding by the metalloprotease-disintegrin ADAM8, Biological Chemistry, 387, 3, (2006).
- Thomas Tousseyn, Ellen Jorissen, Karina Reiss and Dieter Hartmann, (Make) Stick and cut loose—Disintegrin metalloproteases in development and disease, Birth Defects Research Part C: Embryo Today: Reviews, 78, 1, (24-46), (2006).
- Ramana Gutala, Ju Wang, Yoon Y. Hwang, Riaz Haq and Ming D. Li, Nicotine modulates expression of amyloid precursor protein and amyloid precursor-like protein 2 in mouse brain and in SH-SY5Y neuroblastoma cells, Brain Research, 1093, 1, (12), (2006).
- D. T. Kobayashi and K. S. Chen, Behavioral phenotypes of amyloid‐based genetically modified mouse models of Alzheimer's disease, "Genes, Brain and Behavior", 4, 3, (173-196), (2005).
- Rafal M. Smigrodzki and Shaharyar M. Khan, Mitochondrial Microheteroplasmy and a Theory of Aging and Age-Related Disease, Rejuvenation Research, 8, 3, (172), (2005).
- Sandra Rebelo, Ana Gabriela Henriques, Edgar F. da Cruz e Silva and Odete A.B. da Cruz e Silva, Effect of cell density on intracellular levels of the Alzheimer's amyloid precursor protein, Journal of Neuroscience Research, 76, 3, (406-414), (2004).
- Stefan F. Lichtenthaler and Christian Haass, Amyloid at the cutting edge: activation of α-secretase prevents amyloidogenesis in an Alzheimer disease mouse model, Journal of Clinical Investigation, 113, 10, (1384), (2004).
- Rolf Postina, Anja Schroeder, Ilse Dewachter, Juergen Bohl, Ulrich Schmitt, Elzbieta Kojro, Claudia Prinzen, Kristina Endres, Christoph Hiemke, Manfred Blessing, Pascaline Flamez, Antoine Dequenne, Emile Godaux, Fred van Leuven and Falk Fahrenholz, A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model, Journal of Clinical Investigation, 113, 10, (1456), (2004).
- Nicola J. Webster, Kim N. Green, Victoria J. Settle, Chris Peers and Peter F.T. Vaughan, Altered processing of the amyloid precursor protein and decreased expression of ADAM 10 by chronic hypoxia in SH-SY5Y: no role for the stress-activated JNK and p38 signalling pathways, Molecular Brain Research, 130, 1-2, (161), (2004).
- Corinna Van Den Heuvel, James J. Donkin, John W. Finnie, Peter C. Blumbergs, Tim Kuchel, Barbara Koszyca, Jim Manavis, Nigel R. Jones, Peter L. Reilly and Robert Vink, Downregulation of Amyloid Precursor Protein (APP) Expression following Post-Traumatic Cyclosporin-A Administration, Journal of Neurotrauma, 21, 11, (1562), (2004).
- Rie Yamamoto, Shinji Yoneda and Hideaki Hara, Neuroprotective effects of β-secretase inhibitors against rat retinal ganglion cell death, Neuroscience Letters, 370, 1, (61), (2004).
- Tobias M.J. Allinson, Edward T. Parkin, Anthony J. Turner and Nigel M. Hooper, ADAMs family members as amyloid precursor protein α‐secretases, Journal of Neuroscience Research, 74, 3, (342-352), (2003).
- Donat Kögel, Robert Schomburg, Tina Schürmann, Claus Reimertz, Hans‐Georg König, Monika Poppe, Anne Eckert, Walter E. Müller and Jochen H. M. Prehn, The amyloid precursor protein protects PC12 cells against endoplasmic reticulum stress‐induced apoptosis, Journal of Neurochemistry, 87, 1, (248-256), (2003).
- Bruno P. Imbimbo and Francesca Speroni, β‐Amyloid Therapeutic Strategies for Alzheimer's Disease, Burger's Medicinal Chemistry and Drug Discovery, (2005).
- Yu Qiu, Hong-zhuan Chen, Xing-jun Wu and Zheng-jun Jin, 6β-Acetoxy nortropane regulated processing of amyloid precursor protein in CHOm1 cells and rat brain, European Journal of Pharmacology, 468, 1, (1), (2003).
- Paul R Turner, Kate O’Connor, Warren P Tate and Wickliffe C Abraham, Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory, Progress in Neurobiology, 70, 1, (1), (2003).
- Francis V. DeFeudis, Effects of Ginkgo biloba extract (EGb 761) on gene expression: Possible relevance to neurological disorders and age‐associated cognitive impairment, Drug Development Research, 57, 4, (214-235), (2003).
- Nicola J. Webster, Kim N. Green, Chris Peers and Peter F. T. Vaughan, Altered processing of amyloid precursor protein in the human neuroblastoma SH‐SY5Y by chronic hypoxia, Journal of Neurochemistry, 83, 6, (1262-1271), (2002).
- Mark P. Mattson, [38] Involvement of superoxide in pathogenic action of mutations that cause Alzheimer's disease, Redox Cell Biology and Genetics Part A, 10.1016/S0076-6879(02)52040-1, (455-474), (2002).
- Guanjun Cheng, ZaiFang Yu, Daohong Zhou and Mark P. Mattson, Phosphatidylinositol-3-Kinase–Akt Kinase and p42/p44 Mitogen-Activated Protein Kinases Mediate Neurotrophic and Excitoprotective Actions of a Secreted Form of Amyloid Precursor Protein, Experimental Neurology, 175, 2, (407), (2002).
- Steven W. Barger and Anthony S. Basile, Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function, Journal of Neurochemistry, 76, 3, (846-854), (2008).
- Martin Hersberger, Juan Santiago‐Garcia, Susannah Patarroyo‐White, Jimmy Yan and Xiao Xu, A dinucleotide deletion in amyloid precursor protein (APP) mRNA associated with sporadic Alzheimer's disease results in efficient secretion of truncated APP isoforms from neuroblastoma cell cultures, Journal of Neurochemistry, 76, 5, (1308-1314), (2001).
- Ikuroh Ohsawa, Chizuko Takamura and Shinichi Kohsaka, Fibulin‐1 binds the amino‐terminal head of β‐amyloid precursor protein and modulates its physiological function, Journal of Neurochemistry, 76, 5, (1411-1420), (2001).
- Chengbiao Lu, Sic L. Chan, Norman Haughey, Way‐Tso Lee and Mark P. Mattson, Selective and biphasic effect of the membrane lipid peroxidation product 4‐hydroxy‐2,3‐nonenal on N‐methyl‐d‐aspartate channels, Journal of Neurochemistry, 78, 3, (577-589), (2001).
- Yolanda Ruiz‐León and Angel Pascual, Brain‐derived neurotrophic factor stimulates β‐amyloid gene promoter activity by a Ras‐dependent/AP‐1‐independent mechanism in SH‐SY5Y neuroblastoma cells, Journal of Neurochemistry, 79, 2, (278-285), (2008).
- S. Roßner, K. Mendla, R. Schliebs and V. Bigl, Protein kinase Cα and β1 isoforms are regulators of α‐secretory proteolytic processing of amyloid precursor protein in vivo, European Journal of Neuroscience, 13, 8, (1644-1648), (2001).
- Diana Ines Dominguez, Bart De Strooper and Wim Annaert, Secretases as therapeutic targets for the treatment of Alzheimer's disease, Amyloid, 8, 2, (124), (2001).
- Mark P. Mattson, Inflammation, Free Radicals, Glycation, Metabolism and Apoptosis, and Heavy Metals, Functional Neurobiology of Aging, 10.1016/B978-012351830-9/50025-1, (349-371), (2001).
- Catherine McKeon-O'Malley and Rudolph Tanzi, Etiology, Genetics, and Pathogenesis of Alzheimer's Disease, Functional Neurobiology of Aging, 10.1016/B978-012351830-9/50024-X, (333-348), (2001).
- Albert R. La Spada, Ying-Hui Fu, Bryce L. Sopher, Randell T. Libby, Xuejiao Wang, Lili Y. Li, David D. Einum, Jing Huang, Daniel E. Possin, Annette C. Smith, Refugio A. Martinez, Kari L. Koszdin, Piper M. Treuting, Carol B. Ware, James B. Hurley, Louis J. Ptáček and Shiming Chen, Polyglutamine-Expanded Ataxin-7 Antagonizes CRX Function and Induces Cone-Rod Dystrophy in a Mouse Model of SCA7, Neuron, 31, 6, (913), (2001).
- Ayako Yamamoto and Christian Behl, Human Nck-associated protein1 and its binding protein affect the metabolism of beta-amyloid precursor protein with Swedish mutation, Neuroscience Letters, 316, 1, (50), (2001).
- Amanda Mishizen, Milos Ikonomovic and David M. Armstrong, Glutamate Receptors in Aging and Alzheimer's Disease, Functional Neurobiology of Aging, 10.1016/B978-012351830-9/50022-6, (283-314), (2001).
- Mark P. Mattson, Qing Guo, Wenzhuan Duan and Sic L. Chan, Neuronal apoptosis and the pathogenesis of Alzheimer's and Parkinson's diseases, Programmed Cell Death Volume II, 10.1016/S1566-3124(01)06007-2, (169-204), (2001).
- Lorraine A DeGiorgio, Nicole DeGiorgio, Teresa A Milner, Bruno Conti and Bruce T Volpe, Neurotoxic APP C-terminal and β-amyloid domains colocalize in the nuclei of substantia nigra pars reticulata neurons undergoing delayed degeneration, Brain Research, 874, 2, (137), (2000).
- Mark P. Mattson, Apoptotic and Anti‐Apoptotic Synaptic Signaling Mechanisms, Brain Pathology, 10, 2, (300-312), (2006).
- Eliezer Masliah, Michael Alford, Margaret Mallory, Edward Rockenstein, Dieder Moechars and Fred Van Leuven, Abnormal Glutamate Transport Function in Mutant Amyloid Precursor Protein Transgenic Mice, Experimental Neurology, 163, 2, (381), (2000).
- James R Stone, Richard H Singleton and John T Povlishock, Antibodies to the C-terminus of the β-amyloid precursor protein (APP): a site specific marker for the detection of traumatic axonal injury, Brain Research, 871, 2, (288), (2000).
- Ikuroh Ohsawa, Chizuko Takamura, Takako Morimoto, Mariko Ishiguro and Shinichi Kohsaka, Amino‐terminal region of secreted form of amyloid precursor protein stimulates proliferation of neural stem cells, European Journal of Neuroscience, 11, 6, (1907-1913), (2008).
- Kurt Heininger, A unifying hypothesis of Alzheimer's disease. II. Pathophysiological processes, Human Psychopharmacology: Clinical and Experimental, 14, 8, (525-581), (1999).
- James G. Begley, Wenzhen Duan, Sic Chan, Karen Duff and Mark P. Mattson, Altered Calcium Homeostasis and Mitochondrial Dysfunction in Cortical Synaptic Compartments of Presenilin‐1 Mutant Mice, Journal of Neurochemistry, 72, 3, (1030-1039), (2008).
- A. Cedazo-Minguez, L. Bonecchi, B. Winblad, C. Post, E.H.F. Wong, R.F. Cowburn and L. Benatti, Nicergoline stimulates protein kinase C mediated α-secretase processing of the amyloid precursor protein in cultured human neuroblastoma SH-SY5Y cells, Neurochemistry International, 35, 4, (307), (1999).
- Storey and Cappai, The amyloid precursor protein of Alzheimer’s disease and the Aβ peptide, Neuropathology and Applied Neurobiology, 25, 2, (81-97), (2002).
- MARK P. MATTSON, WARD A. PEDERSEN, WENZHEN DUAN, CARSTEN CULMSEE and SIMONETTA CAMANDOLA, Cellular and Molecular Mechanisms Underlying Perturbed Energy Metabolism and Neuronal Degeneration in Alzheimer's and Parkinson's Diseases, Annals of the New York Academy of Sciences, 893, 1, (154-175), (2006).
- J Mills and P.B Reiner, Mitogen-activated protein kinase is involved in N-methyl-d-aspartate receptor regulation of amyloid precursor protein cleavage, Neuroscience, 10.1016/S0306-4522(99)00381-4, 94, 4, (1333-1338), (1999).
- Mark P. Mattson, Zhi Hong Guo and Jonathan D. Geiger, Secreted Form of Amyloid Precursor Protein Enhances Basal Glucose and Glutamate Transport and Protects Against Oxidative Impairment of Glucose and Glutamate Transport in Synaptosomes by a Cyclic GMP‐Mediated Mechanism, Journal of Neurochemistry, 73, 2, (532-537), (2002).
- Mark P. Mattson and Qing Guo, ■ REVIEW : The Presenilins, The Neuroscientist, 5, 2, (112), (1999).
- Mark P. Mattson, Chapter 1 Genetic Contributions to the Pathogenesis of Alzheimer's Disease, Genetic Aberrancies and Neurodegenerative Disorders, 10.1016/S1566-3124(08)60021-8, (1-31), (1999).
- Qing Guo, Lois Sebastian, Bryce L. Sopher, Miles W. Miller, Carol B. Ware, George M. Martin and Mark P. Mattson, Increased Vulnerability of Hippocampal Neurons from Presenilin‐1 Mutant Knock‐In Mice to Amyloid β‐Peptide Tox, Journal of Neurochemistry, 72, 3, (1019-1029), (2008).
- G.R Dawson, G.R Seabrook, H Zheng, D.W Smith, S Graham, G O'Dowd, B.J Bowery, S Boyce, M.E Trumbauer, H.Y Chen, L.H.T Van der Ploeg and D.J.S Sirinathsinghji, Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the β-amyloid precursor protein, Neuroscience, 90, 1, (1), (1999).
- J.J. Anderson, G. Holtz, P.P. Baskin, R. Wang, L. Mazzarelli, S.L. Wagner and F. Menzaghi, Reduced cerebrospinal fluid levels of α-secretase-cleaved amyloid precursor protein in aged rats: correlation with spatial memory deficits, Neuroscience, 93, 4, (1409), (1999).
- X. Xu, D. Yang, T. Wyss-Coray, J. Yan, L. Gan, Y. Sun and L. Mucke, Wild-type but not Alzheimer-mutant amyloid precursor protein confers resistance against p53-mediated apoptosis, Proceedings of the National Academy of Sciences, 96, 13, (7547), (1999).
- E Van Uden, I Veinbergs, M Mallory, R Orlando and E Masliah, A novel role for receptor-associated protein in somatostatin modulation: implications for Alzheimer's disease, Neuroscience, 88, 3, (687), (1999).
- Mark P. Mattson and Wenzhen Duan, “Apoptotic” biochemical cascades in synaptic compartments: Roles in adaptive plasticity and neurodegenerative disorders, Journal of Neuroscience Research, 58, 1, (152-166), (1999).
- Takako Morimoto, Ikuroh Ohsawa, Chizuko Takamura, Mariko Ishiguro and Shinichi Kohsaka, Involvement of amyloid precursor protein in functional synapse formation in cultured hippocampal neurons, Journal of Neuroscience Research, 51, 2, (185-195), (1998).
- K Furukawa and M.P Mattson, Secreted amyloid precursor protein α selectively suppresses N-methyl-d-aspartate currents in hippocampal neurons: involvement of cyclic GMP, Neuroscience, 83, 2, (429), (1998).
- Mark P. Mattson and Ward A. Pedersen, Effects of amyloid precursor protein derivatives andoxidative stress on basal forebrain cholinergic systems inALZHEIMERS disease, International Journal of Developmental Neuroscience, 16, 7-8, (737), (1998).
- Anna Henry, Qiao‐Xin LI, Denise Galatis, Lars Hesse, Gerd Multhaup, Konrad Beyreuther, Colin L. Masters and Roberto Cappai, Inhibition of platelet activation by the Alzheimer's disease amyloid precursor protein, British Journal of Haematology, 103, 2, (402-415), (2002).
- C. Galli, A. Piccini, M. T. Ciotti, L. Castellani, P. Calissano, D. Zaccheo and M. Tabaton, Increased amyloidogenic secretion in cerebellar granule cells undergoing apoptosis, Proceedings of the National Academy of Sciences, 95, 3, (1247), (1998).
- Young Hae Chong, Ju Young Seoh and Hae Kyung Park, Increased activity of matrix metalloproteinase-2 in human glial and neuronal cell lines treated with HIV-1 gp41 peptides, Journal of Molecular Neuroscience, 10, 2, (129), (1998).
- Magdalena Sastre, R. Scott Turner and Efrat Levy, X11 Interaction with β-Amyloid Precursor Protein Modulates Its Cellular Stabilization and Reduces Amyloid β-Protein Secretion, Journal of Biological Chemistry, 273, 35, (22351), (1998).
- Qing Guo, Nic Robinson and Mark P. Mattson, Secreted β-Amyloid Precursor Protein Counteracts the Proapoptotic Action of Mutant Presenilin-1 by Activation of NF-κB and Stabilization of Calcium Homeostasis, Journal of Biological Chemistry, 273, 20, (12341), (1998).
- Q. Guo, S. Christakos, N. Robinson and M. P. Mattson, Calbindin D28k blocks the proapoptotic actions of mutant presenilin 1: Reduced oxidative stress and preserved mitochondrial function, Proceedings of the National Academy of Sciences, 95, 6, (3227), (1998).
- Eliezer Masliah, Jacob Raber, Michael Alford, Margaret Mallory, Mark P. Mattson, Daseng Yang, Derek Wong and Lennart Mucke, Amyloid Protein Precursor Stimulates Excitatory Amino Acid Transport, Journal of Biological Chemistry, 273, 20, (12548), (1998).
- Kenji Takase, Reactions of denatured proteins with other cellular components to form insoluble aggregates and protection by lactoferrin, FEBS Letters, 441, 2, (271-274), (1999).
- Mark P. Mattson, Advances fuel Alzheimer's conundrum, Nature Genetics, 17, 3, (254), (1997).
- Mark P Mattson, Steven W Barger, Katsutoshi Furukawa, Annadora J Bruce, Tony Wyss-Coray, Robert J Mark and Lennart Mucke, Cellular signaling roles of TGFβ, TNFα and βAPP in brain injury responses and Alzheimer's disease, Brain Research Reviews, 23, 1-2, (47), (1997).
- Wei Wang and Kimberly E Dow, Effects of neuronal proteoglycans on activity-dependent growth responses of fetal hippocampal neurons, Molecular Brain Research, 48, 2, (355), (1997).
- Mark P. Mattson and Qing Guo, Cell and molecular neurobiology of presenilins: A role for the endoplasmic reticulum in the pathogenesis of Alzheimer's disease?, Journal of Neuroscience Research, 50, 4, (505-513), (1998).
- S Hunter and C Brayne, Understanding the roles of mutations in the amyloid precursor protein in Alzheimer disease, Molecular Psychiatry, 10.1038/mp.2017.218, (2017).
- Arif Tasleem Jan, Mudsser Azam, Safikur Rahman, Angham M. S. Almigeiti, Duk Hwan Choi, Eun Ju Lee, Qazi Mohd Rizwanul Haq and Inho Choi, Perspective Insights into Disease Progression, Diagnostics, and Therapeutic Approaches in Alzheimer's Disease: A Judicious Update, Frontiers in Aging Neuroscience, 10.3389/fnagi.2017.00356, 9, (2017).
- Chaoqun Wang, Yikai Shou, Jie Pan, Yue Du, Cuiqing Liu and Huanhuan Wang, The relationship between cholesterol level and Alzheimer’s disease-associated APP proteolysis/Aβ metabolism, Nutritional Neuroscience, 10.1080/1028415X.2017.1416942, (1-11), (2018).
- Bruce G. Mockett, Max Richter, Wickliffe C. Abraham and Ulrike C. Müller, Therapeutic Potential of Secreted Amyloid Precursor Protein APPsα, Frontiers in Molecular Neuroscience, 10.3389/fnmol.2017.00030, 10, (2017).
- Dimitri Hefter and Andreas Draguhn, APP as a Protective Factor in Acute Neuronal Insults, Frontiers in Molecular Neuroscience, 10.3389/fnmol.2017.00022, 10, (2017).




